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Summary
The most frequent forms of inherited thrombocytopenia (IT) are
characterized by platelet size abnormalities and it has been suggested that
this parameter is useful for their differentiation from immune thrombocy-
topenia (ITP). Recently, a monocentric study identified cut-off values for
mean platelet volume (MPV) and mean platelet diameter (MPD) with
good diagnostic accuracy in this respect. To validate these cut-off values in
a different and larger case series of patients, we enrolled 130 subjects with
ITP and 113 with IT in six different centres. The platelet count and MPV
was each measured by the instrument routinely used in each institution. In
some centres, platelet count was also measured by optical microscopy.
MPD was evaluated centrally by image analysis of peripheral blood films.
The previously identified cut-off value for MPV had 91% specificity in
distinguishing ITP from inherited macrothrombocytopenias (mono and
biallelic Bernard-Soulier, MYH9-related disease), while its sensitivity was
greatly variable depending on the instrument used. With an appropriate
instrument, specificity was 83%. The diagnostic accuracy of MPD was
lower than that obtained with MPV. We concluded that MPV is a useful
parameter for differentiating ITP from IT provided that it is measured by
appropriate cell counters.
Keywords: inherited thrombocytopenias, immune thrombocytopenia,
platelet volume, platelet diameter, platelet size.
Distinguishing immune thrombocytopenia (ITP) from inher-
ited thrombocytopenias (ITs) is not always easy, and several
patients with inherited forms have received unnecessary
medical treatments or even splenectomy because they were
misdiagnosed with ITP (Bader-Meunier et al, 2003; Noris
et al, 2004, 2012; Kunishima et al, 2006; Gunay-Aygun et al,
2010; Savoia et al, 2011). Differential diagnosis may be especially
difficult when a low platelet count, which can be used to
decide whether thrombocytopenia is acquired or congenital,
is incidentally discovered in asymptomatic subjects who have
never had a blood count performed before. In some cases,
family history may solve the diagnostic dilemma, in that the
presence of other relatives with low platelet counts strongly
argues against ITP and supports an inherited form. Conversely,
the absence of affected family members by no means excludes
genetic disorders because many ITs are transmitted in a
recessive fashion or derive from de novo mutations.
As many forms of IT are characterized by platelet macro-
cytosis (Balduini & Savoia, 2012), it is commonly accepted
that the evaluation of platelet size is an important tool to
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provoke suspicion of these disorders. However, the accurate
measurement of platelet size in IT subjects presents notable
difficulties because some of the less rare forms, such as
MYH9-related disease (MYH9-RD), monoallelic Bernard-
Soulier syndrome (BSS) and biallelic BSS, may present plate-
lets that, due to their very large size, are not recognized by
the electronic counters, which therefore underestimates not
only the platelet count but also the mean platelet volume
(MPV) (Balduini et al, 2011; Savoia et al, 2011; Noris et al,
2012). Moreover, instruments operating on different princi-
ples also induce variability into the measurement of MPV in
healthy subjects or in subjects with non-macrocytic thrombo-
cytopenias, thus making difficult the direct comparison of
MPV values obtained in different centres (Latger-Cannard
et al, 2012).
A possible alternative for the evaluation of platelet size is
microscopic examination of peripheral blood smears, which
recognizes platelets regardless of their size and thus makes
possible accurate measurement of their diameters (Noris
et al, 2009). However, this method also has drawbacks in
that it is time consuming and requires experienced operators.
Finally, a major problem for the use of platelet size in differ-
entiating ITs from ITP was represented until recently by the
lack of cut-off values for both MPV and mean platelet diam-
eter (MPD).
To remedy the last difficulty, a recent, monocentric study
measured platelet size in patients with inherited macro-
thrombocytopenias and ITP by both cell counters and optical
microscopy on blood films. It found that both techniques
were effective in distinguishing the two conditions, in that
a MPV higher than 124 fl measured with an optical cell
counter (ADVIA 120) and a MPD larger than 33 lm had
sensitivity and specificity higher than 80% (Noris et al, 2009).
To validate these cut-off values, we performed a multicen-
tre study in a different series of patients, which enrolled 113
consecutive patients with ITs and 130 patients with ITP.
Patients and methods
Patients
All of the patients with ITs or ITP examined in the six clini-
cal centres involved in this project between January 2010 and
January 2012 were enrolled in the study. All of them were
Italian. Their main characteristics are reported in Table I.
Diagnosis of ITP was made according to the recommenda-
tions of the ‘International consensus report on the investiga-
tion and management of primary immune thrombocytopenia’
(Provan et al, 2010). The diagnosis of IT was made in
subjects who had been thrombocytopenic since birth with no
identifiable cause of low platelet count and in cases where
thrombocytopenia was clearly transmitted in a hereditary
manner. The search for specific forms of inherited thrombocy-
topenias was made by the diagnostic algorithm of the Italian
‘Gruppo di Studio delle Piastrine’ (Platelet Study Group)
(Balduini et al, 2003; Noris et al, 2004). Patients with an IT
that did not fit the criteria for any known genetic disorder
were classified as affected by a form of unknown origin.
This study was approved by the ethical committee of each
clinical institution and patients gave informed consent to
participate.
Platelet analyses
Platelet counts and MPVs were obtained by the cell counters
used routinely in each centre without any specific recom-
mendation to the laboratory technicians performing the test.
Analyses were executed within 3 h after sampling. The
instruments used in different centres were as follows:
Centre 1: Cell-Dyn 3700 (Abbott, Lake Forest, IL, USA),
using the optical channel of the instrument;
Centre 2: HeCo 5 (Radim-Seac, Florence, Italy), which
analyses platelets by an impedentiometric method;
Centre 3: This centre initially used an ADVIA 2120 (Sie-
mens, Tarrytown, NY, USA), which used the optical
method, then a Cell-Dyn 3700 (Abbott), using the imped-
ance channel of the instrument;
Centre 4: XE-2100 (Sysmex Corporation, Kobe, Japan)
(impedance method);
Centre 5: ADVIA 2120i (Siemens, optical method);
Centre 6: ADVIA 120 (Siemens, optical method).
As it is well known that MPV varies according to the cell
counter used, the value measured in each subject was
expressed not only as an absolute value, but also as % differ-
ence with respect to the median value obtained in 30 healthy
subjects analysed at each centre with the same instrument.
To verify the consistency of our findings, the same analyses
were performed by using the Z-score, with similar results
(data not shown). In the earlier study that determined the
best cut-off value of MPV to be 124 fl for differentiating
inherited macrothrombocytopenias from ITP, the median
MPV of control subjects was 82 fl (Noris et al, 2009).
Thus, this cut-off value was transformed in an increase
of more than 51% with respect to the median value in
controls.
Whenever available, the platelet count was also measured
by optical microscopy (Noris et al, 2009). EDTA-anticoagu-
lated blood was diluted in ammonium oxalate solution and
the counting procedure was performed in a Neubauer cham-
ber, as indicated by the International Committee for Stan-
dardization in Haematology (England et al, 1988).
The assessment of MPD was centralized. Blood smears
were prepared in each centre from blood obtained by finger
stick and were shipped to the centre that performed the test.
Here, blood films were stained with May–Gr€unwald–Giemsa
and the largest diameter of each platelet was measured by
optical microscopy with software-assisted image analysis
(Axio-vision 4.5; Carl Zeiss, G€ottingen, Germany). For each
subject, the MPD was the median value obtained in 200 cell
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measurements. To identify the normal values of this parame-
ter, MPD was measured in 50 healthy subjects.
Statistical analysis
Descriptive statistics were computed as median and 25th–75th
percentiles for continuous variables and as counts and % for
categorical variables. The Kruskall–Wallis test was used to
compare MPV (transformed, see above) and MPD between
diagnostic groups. The diagnostic accuracy (sensitivity, speci-
ficity and predictive values, and 95% confidence intervals
[95% CI]) to distinguish inherited macrothrombocytopenia
from ITP according to MPD (cut-off >33 lm) and MPV
(cut-off >51%) was assessed. Receiver-operated characteristic
(ROC) curve analysis was used to identify optimal cut-offs for
MPV and MPD and selected diagnostic groups.
Stata 12.1 (StataCorp, College Station, TX, USA) and
Medcalc 12.3 (MedCalc Software, Broekstraat 52, 9030
Mariakerke, Belgium) were used for computation. A 2-sided
P-value <005 was considered statistically significant. The
Bonferroni correction was used for post-hoc comparisons.
Results
Patients
Two hundred and forty-three patients were enrolled in the
study. One hundred and thirty were affected by primary ITP in
any phase of the disease (newly diagnosed n = 25, persistent
ITP n = 20 and chronic ITP n = 85) and 113 by ITs. In partic-
ular, 32 subjects hadMYH9-RD (Balduini et al, 2011), two had
biallelic BSS (Savoia et al, 2011), 12 had monoalleic BSS due to
Bolzano mutation in GP1BA (Noris et al, 2012), 37 had a form
of autosomal dominant thrombocytopenia deriving from
ANKRD26 mutations (ANKRD26-RT) (Noris et al, 2011), and
three an autosomal dominant thrombocytopenia due to an
integrin beta3 mutation (ITGA2B/ITGB3-RT) (Gresele et al,
2009). All these diagnoses were confirmed by the identification
of the causative mutations. MYH9-RD, mono and biallelic BSS
and ITGA2B/ITGB3-RT are currently classified as inherited
macrothrombocytopenias, while ANKRD26-RT has been
reported to have platelets of normal size (Balduini et al, 2011).
Twenty-seven patients did not fit the criteria for any
known disorder and were classified as affected by an IT of
unknown origin. The number of patients with ITs was higher
than expected compared to ITP, but this largely derived from
a bias in enrolment because two centres involved in the
study are particularly interested in ITs both in terms of clini-
cal care and scientific research. Thus, the composition of this
case series cannot be used for epidemiological considerations.
Platelet count
Median platelet counts measured by electronic counters in
different categories of patients are reported in Table II,T
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together with the available values obtained by microscope
counting. As it is well known that microscope counting is
largely operator-dependent, the differences between the
results obtained with the two methods are not surprising.
However, in most cases of inherited macrothrombocytope-
nias, platelet counts measured by the counters were lower
than those measured by microscope. In some cases, as in the
patients with MYH9-RD investigated in Centre 2 and sub-
jects with biallelic BSS evaluated in Centre 1, discrepancies
between the two methodologies were very large. Given that
MYH9-RD and biallelic BSS are characterized by the presence
of very large platelets, a possible explanation for these
discrepancies is that the electronic counters underestimated
platelet count because they did not recognize the largest
elements. As very large platelets can also be observed in ITP
(see below), the same phenomenon could explain the much
higher platelet counts obtained by microscope methodology
in patients with this disorder examined in Centres 2 and 4.
Platelet volume and platelet diameter
Table III reports the medians of the values of MPV and
MPD measured in patients with different categories of
thrombocytopenias examined in each centre as well as in
controls. Concerning MPV, it is important to note that the
two impedentiometric counters used in Centres 3 and 4 did
not give the MPV values for 10 of 20 patients with ITP and
in a few cases of MYH9-RD or IT of unknown origin. Failure
of impedentiometric instruments in measuring MPV in a
large percentage of subjects with enlarged platelets is not new
and has been attributed to abnormalities of platelet distribu-
tion curves (Noris et al, 2009).
Another interesting observation is that the MPV of
MYH9-RD patients was much higher in Centre 1 than in
Centre 2 although MPD was quite similar. Together with the
already discussed discrepancies between platelet counts
obtained in Centre 2 by cell counter and microscope, this
observation strongly supports the hypothesis that the
impedentiometric instrument of this institution had major
problems in recognizing large platelets of MYH9-RD and
therefore greatly underestimated both platelet count and
platelet volume.
The median MPV, expressed as % with respect to the
median value of healthy subjects, was significantly higher
than controls in MYH9-RD, monoallelic and biallelic BSS,
ITGA2B/ITGB3-RT and ITs of unknown origin (Fig 1). MPV
was higher than control also in ITP, where similar values
have been observed in all stages of the disease (data not
shown). In contrast, the MPV of patients with ANKRD26-RT
was not different from that obtained in healthy subjects.
These results confirm that platelets have normal volume in
ANKRD26-RT (Noris et al, 2011) and substantiate the cur-
rent classification of MYH9-RD, BSS and ITGA2B/ITGB3-RT
as macrothrombocytopenias (Balduini et al, 2011). Moreover,
it is important to reiterate that the cell counter used byT
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Centre 2 greatly underestimated MPV in MYH9-RD. On this
basis, we suggest that the actual MPV in this disorder is
higher than that reported in Fig 1 and that the value
obtained in Centre 1 (249% of controls, see Table III) better
describes MPV in MYH9-RD.
The MPV of patients with MYH9-RD and monoallelic BSS
was significantly higher also with respect to ITP. Conversely,
the average MPV in ITP was not significantly different from
those measured in biallelic BSS, ITs of unknown origin and
ITGA2B/ITGB3-RT, while it was significantly higher than in
ANKRD26-RT. Despite these statistically significant differ-
ences, the values obtained in all ITs largely overlapped those
observed in ITP.T
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Fig 1. Mean platelet volume (MPV) and mean platelet diameter
(MPD) in different categories of subjects. To allow comparison of
the values obtained with different cell counters, MPV was expressed
as median % difference with respect to the median MPV observed in
controls. Medians (line within the boxes), standard deviation
(boxes), 25th–75th percentiles (boxes), non-outlier extremes (whiskers)
and outliers (dots) are reported. The cut-off values for distinguishing
immune thrombocytopenia (ITP) from MYH9-RD, mono- and
biallelic-Bernard-Soulier syndrome (BSS) are indicated by dashed
lines. Kruskall Wallis test: P < 0001 for both MPV and MPD
comparisons between groups. * P < 005, ** P < 001 with respect to
control; ° P < 005, °° P < 001 with respect to ITP, after Bonferroni
correction.
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The median values of MPD in patients enrolled in each
centre are reported in Table III together with the values
obtained in controls. The median values in different catego-
ries of patients and controls are reported in Fig 1. Platelet
diameters obtained in each category of subjects enrolled in
different centres were similar, and this observation further
supports the hypothesis that the observed variability of
MPV was dependent on the cell counters used. As for
MPV, the MPD was also higher than controls in patients
with MYH9-RD, monoallelic and biallelic BSS, ITGA2B/
ITGB3-RT, ITs of unknown origin and ITP. Instead, in
contrast to MPV, MPD was also significantly higher than
controls in ANKRD26-RT.
As shown in Fig 1, MPD was significantly higher than ITP
in MYH9-RD and biallelic BSS, while it was lower than ITP
in ANKRD26-RT. Of note, as for MPV, the variability of
platelet diameters within each category of patients was large.
As the measure of MPDs was centralized, we can exclude
that technical differences played an important role in this
variability, which, therefore has to be considered actual.
Investigating the role of differences in genetic background,
causative mutations, age or sex in this variability requires a
very large number of patients for each disorder and, there-
fore, was not an aim of our study.
Specificity and sensibility of the previously identified
cut-off values of MPV and MPD in differentiating
inherited thrombocytopenias from ITP
The already discussed cut-off values of MPV and MPD for
distinguishing between inherited macrothrombocytopenias
and ITP were identified by the study of subjects with MYH9-
RD and monoallelic or biallelic BSS, in addition to ITP sub-
jects (Noris et al, 2009). Thus, to confirm their effectiveness,
we applied them to the patients of our case series with the
same disorders.
The limit for MPV of more than 51% with respect to
controls had 915% specificity (95% CI 848–958) and 659%
(95% CI 501–795) sensitivity in distinguishing the above
disorders from ITP. Based on the observed prevalence, the
positive predictive value was 744% (95% CI 579–87) and
the negative predictive value was 877% (95% CI 805–93).
To correctly interpret these findings it is necessary to note
that they derived from data obtained by various cell counters
with different ability to recognize abnormally large platelets.
We suggest that the 915% specificity emerging from global
analysis is overestimated because the impedentiometric coun-
ters used in Centres 3 and 4 did not give the MPV in 10 ITP
patients, in all likelihood due to the presence of very large
platelets. We also suggest that the 659% sensitivity obtained
in the global analysis underestimates the potential usefulness
of MPV in differentiating inherited macrothrombocytopenias
from ITP. As already discussed, the impedentiometric coun-
ter used in Centre 2 had a major problem in recognizing
very large platelets and, as a consequence, none of the
patients with inherited macrothrombocytopenias had a MPV
higher than 51% of controls (sensitivity = 0%). Conversely,
25 of the 30 subjects with inherited macrothrombocytopenias
examined in Centre 1 had MPVs higher than the cut-off
value and the sensitivity of the test was 833% (95% CI
653–944).
As already reported, patients with ITGA2B/ITGB3-RT or
an IT of unknown origin had MPV similar to ITP. Thus, the
examined cut-off value for MPV has no role in differentiat-
ing these disorders. However, since MPV was significantly
lower in ANKRD26-RT than in ITP, we searched by ROC
analysis the ‘optimal’ cut-off value for discriminating
between these conditions and measured its predictive value.
Results of this analysis revealed that the best cut-off value
was a MPV lower by more than 8% with respect to controls
and that it had 541% sensitivity (95% CI 369–705)
and 821% specificity (95% CI 739–885) in distinguishing
ANKRD26-RT from ITP.
Concerning the cut-off value of 33 lm for MPD, it had
669% (95% CI 581–749) specificity and 755% (95% CI
611–867) sensitivity in differentiating MYH9-RD and
monoallelic or biallelic BSS from ITP. Positive predictive
value was 463% (95% CI 35–578) and negative predictive
value 879 (95% CI 798–936). As for MPV, also MPD was
lower in ANKRD26-RT than in ITP and we therefore
searched for the best cut-off value for differentiating these
conditions. We found that a platelet diameter of less than
30 lm had 784% sensitivity and 531% specificity in distin-
guishing ANKRD26-RT from ITP.
Discussion
Platelet size is enlarged in many forms of IT and diagnostic
guidelines suggest that this parameter is an important
element for distinguishing these conditions from ITP (Geddis &
Balduini, 2007; Provan et al, 2010). However, this statement is
mainly based on expert opinion, because only one experi-
mental study has addressed this matter in detail to date
(Noris et al, 2009). In a single institution case series of
patients with inherited macrothrombocytopenias (MYH9-RD,
mono and biallelic BSS) and ITP, the authors measured
MPDs by peripheral blood film evaluation and MPVs by two
different blood cell analysers (ADVIA 120 [Bayer, Leverku-
sen, Germany] that uses two-dimensional light scatter and
XE-2100 [Sysmex XE] based on the impedance method), and
searched for the best cut-off values for distinguishing
between ITP and inherited disorders. Results of this study
revealed that both cell counters underestimated platelet
counts in inherited macrothrombocytopenias with respect to
the values obtained by microscope counting in a Neubauer
chamber, although this phenomenon was much more evident
with the impedentiometric counter (Noris et al, 2009).
Moreover, the impedance instrument did not report the
MPV in all the patients with inherited macrothrombocytope-
nia owing to the abnormalities in their platelet volume distri-
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bution curves. Finally, 33 lm for MPD and 124 fl for MPV
measured by the optical counter were identified by ROC
analysis as the best cut-off values for differentiating ITP from
inherited macrothrombocytopenias. Sensitivity and specificity
of MPV were 83% and 89% respectively, while those of
MPD were 89% and 88%. Thus, Noris et al (2009) first dem-
onstrated the effectiveness of platelet size in distinguishing
between these conditions.
The present study aimed at further investigating this
matter in a new, larger series of consecutive patients with
ITP and various forms of IT evaluated in different centres.
While evaluation of MPD was centralized, MPV was mea-
sured in each institution by the haematology analyser used
routinely without any particular recommendation (‘real life’
study).
The results we obtained confirm and extend many of the
findings of previous investigation, but also challenge some
previous conclusions. First of all, we brought new evidence
supporting the inadequacy of the haematological analysers
that rely on impedance in measuring platelet parameters of
subjects with enlarged platelets. Major problems in this
regard have been reported previously with the Sysmex
XE-2100 and the Beckman Coulter LH750 (Noris et al, 2009;
Latger-Cannard et al, 2012), and similar limitations have
been observed in the present study with the Sysmex XE-2100
used in Centre 4 and with the impedentiometric channel of
the Abbott Cell-Dyn 3700 instrument used in Centre 3: both
counters did not measure MPV in several patients with
MYH9-RD, ITs of unknown origin or ITP because of their
inability to recognize very large platelets. Moreover, the
Radim-Seac HeCo 5 analyser used in Centre 2 greatly and
systematically underestimated platelet count and MPV in
subjects with MYH9-RD, who typically have giant platelets.
Conversely, the Siemens ADVIA 2120 and 120, used in Cen-
tres 5 and 6 respectively, to study patients with ITP or ITs of
unknown origin, measured platelet parameters in all exam-
ined cases and gave values of MPV that did not conflict with
platelet diameters evaluated on peripheral blood films. The
ADVIA 120 instrument was previously used in study
reported by Noris et al (2009), which evaluated platelet
parameters in inherited macrothrombocytopenias and ITP
and proved to be more effective than the Sysmex XE-2100
used in parallel, even if it did not recognize platelets with an
extreme degree of platelet macrocytosis. Finally, the optical
channel of the Abbott Cell-Dyn 3700, which was utilized in
Centre 1 to evaluate all the categories of subjects included in
the study, gave platelet counts and MPVs that did not
contrast with those measured by optical microscopy, with
the only exception of the two examined patients with biallelic
BSS, who had their platelet counts and MPVs greatly under-
estimated. Thus, the present data and those from the litera-
ture indicate that all cell counters have problems in
determining platelets in subjects with macrothrombocytope-
nias, but they also suggest the severity of the defect is greatly
variable.
The limitations of some instruments used in our study
explain why, in the whole patient population, the sensitivity
of the cut-off value for MPV of more than 51% with respect
to controls was much lower than that obtained in the previ-
ous investigation that used an ADVIA 120 analyser (65%
versus 83%) (Noris et al, 2009). However, considering only
data obtained by the Abbott Cell-Dyn 3700 instrument in
Centre 1, which examined the vast majority of patients with
ITs enrolled in this study, the sensitivity rose to 83%, a value
identical to that obtained in the prior study. The specificity
of the cut-off value of MPV obtained in present study was
similar to that obtained previously (91% versus 89%),
although, as already discussed in the Results section, it is
possible that this figure was a little overestimated. Thus, the
diagnostic accuracy of the MPV cut-off value largely depends
on the instrument used and is high when a suitable counter
is used. Conversely, the diagnostic accuracy of the MPV
in distinguishing ITP from the non-macrocytic forms of
inherited thrombocytopenias we examined seems to be
unsatisfactory.
MPDs obtained by blood film evaluation classified ITs
similarly to MPV concerning platelet size, with the only
exception of ANKRD26-RT, which had platelets of normal
size based on MPV and slightly enlarged at MPD evalua-
tion. However, the specificity and sensitivity of the cut-off
value of 33 lm were poor in distinguishing inherited mac-
rothrombocytopenias from ITP (67% and 75% respectively)
and were much lower than those obtained by Noris et al
(2009) (88% and 89% respectively). The reason why MPD
was less effective than MPV in this respect is unknown,
since these two parameters are obviously strictly related.
However, MPV is measured in platelet suspended in
plasma, while MPD is evaluated in platelets adhered to
glass slides, and this could make the difference in that it
has been shown that the shape change occurring in
MYH9-RD and BSS platelets during adhesion to glass dif-
fers from that of normal platelets (Milton et al, 1985).
Moreover, MPV, unlike MPD, is measured in anticoagulated
blood and we cannot exclude that the anticoagulant affects
platelet size differently in different disorders. We have also to
consider that the microscope measurement of MPD is a
rather inaccurate test because it is based on the analysis of a
limited number of platelets and is, at least partially, opera-
tor-dependent.
In conclusion, our study showed that platelet size evalua-
tion is a useful tool for distinguishing inherited macrothrombo-
cytopenias from ITP and that the better differentiation is
obtained by the use of the MPV values given by appropriate
cell counters. Inappropriate instruments can be identified
either by comparison of platelet counts measured by the
counter with those obtained by manual counting or by the
evaluation of peripheral blood films, which show very large
platelets in subjects with normal or only slightly enlarged
MPV. From a practical point of view, we suggest that microscope
evaluation of blood films and measurement of MPV by
P. Noris et al
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cell counters should be used in combination. Blood
film examination enables the easy identification of very
large platelets, which suggest a diagnosis of inherited
macrothrombocytopenias. If very large platelets are not iden-
tified, a MPV increased by more than 51% with respect to
controls represents an important element that supports the
suspicion of a hereditary macrothrombocytopenia.
Acknowledgements
This work was supported by grants from Telethon Founda-
tion (n. GGP10089), Cariplo Foundation (2012-0529), and
IRCCS Policlinico San Matteo Foundation (Grant: Ricerca
Corrente 08044500/06), Pavia, Italy.
Authorship
P Noris: enrolled patients, analysed data, wrote the article.
C Klersy: performed statistical analysis, discussed results and
revised the manuscript. P Gresele, F Giona, P Giordano,
P Minuz, G Loffredo: enrolled patients, discussed results and
revised the manuscript. F Melazzini: determined platelet size
and count, collected clinical and laboratory data, prepared tables
and revised the manuscript. AM Mezzasoma, M Piedimonte,
F Semeraro, D Veneri, F Menna, A Pecci: enrolled patients,
collected clinical and laboratory data, and revised the
manuscript. E Civaschi, L Ciardelli: determined platelet
size and count, and revised the manuscript. CL Balduini:
designed the study, analysed data, wrote the article.
References
Bader-Meunier, B., Proulle, V., Trichet, C.,
Debray, D., Gabolde, M., Yvart, J. & Dreyfus,
M. (2003) Misdiagnosis of chronic thrombocy-
topenia in childhood. Journal of Pediatric Hema-
tology/Oncology, 25, 548–552.
Balduini, C.L. & Savoia, A. (2012) Genetics of
familial forms of thrombocytopenia. Human
Genetics, 131, 1821–1832.
Balduini, C.L., Cattaneo, M., Fabris, F., Gresele, P.,
Iolascon, A., Pulcinelli, F.M. & Savoia, A. (2003)
Inherited thrombocytopenias: a proposed diagnos-
tic algorithm from the Italian Gruppo di Studio
delle Piastrine. Haematologica, 88, 582–592.
Balduini, C.L., Pecci, A. & Savoia, A. (2011)
Recent advances in the understanding and man-
agement of MYH9-related inherited thrombocy-
topenias. British Journal of Haematology, 154,
161–174.
England, J.M., Rowan, R.M., Bins, M., Bull, B.S.,
Coulter, W.H., Groner, W., Jones, A.R., Koepke,
J.A., Lewis, S.M., Shinton, N.K., Thom, R., van
Assendelft, O.W. & Verwilghen, R.L. (1988)
Recommended methods for the visual determina-
tion of white cell and platelet counts. http://
whqlibdoc.who.int/hq/1988/WHO_LAB_88.3.pdf.
Geddis, A.E. & Balduini, C.L. (2007) Diagnosis of
immune thrombocytopenic purpura in children.
Current Opinion in Hematology, 14, 520–525.
Gresele, P., Falcinelli, E., Giannini, S., D’Adamo,
P., D’Eustacchio, A., Corazzi, T., Mezzasoma,
A.M., Di Bari, F., Guglielmini, G., Cecchetti, L.,
Noris, P., Balduini, C.L. & Savoia, A. (2009)
Dominant inheritance of a novel integrin beta3
mutation associated with a hereditary macro-
thrombocytopenia and platelet dysfunction in
two Italian families. Haematologica, 94, 663–669.
Gunay-Aygun, M., Zivony-Elboum, Y., Gumruk,
F., Geiger, D., Cetin, M., Khayat, M., Kleta, R.,
Kfir, N., Anikster, Y., Chezar, J., Arcos-Burgos,
M., Shalata, A., Stanescu, H., Manaster, J., Arat,
M., Edwards, H., Freiberg, A.S., Hart, P.S.,
Riney, L.C., Patzel, K., Tanpaiboon, P., Markello,
T., Huizing, M., Maric, I., Horne, M., Kehrel,
B.E., Jurk, K., Hansen, N.F., Cherukuri, P.F.,
Jones, M., Cruz, P., Mullikin, J.C., Nurden, A.,
White, J.G., Gahl, W.A. & Falik-Zaccai, T. (2010)
Gray platelet syndrome: natural history of a
large patient cohort and locus assignment to
chromosome 3p. Blood, 116, 4990–5001.
Kunishima, S., Yamada, T., Hamaguchi, M. &
Saito, H. (2006) Bernard-Soulier syndrome due
to GPIX W127X mutation in Japan is frequently
misdiagnosed as idiopathic thrombocytopenic
purpura. International Journal of Hematotology,
83, 366–367.
Latger-Cannard, V., Hoarau, M., Salignac, S.,
Baumgart, D., Nurden, P. & Lecompte, T.
(2012) Mean platelet volume: comparison of
three analysers towards standardization of plate-
let morphological phenotype. International Jour-
nal of Laboratory Hematology, 34, 300–310.
Milton, J.G., Hutton, R.A., Tuddenham, E.G. &
Frojmovic, M.M. (1985) Platelet size and shape
in hereditary giant platelet syndromes on blood
smear and in suspension: evidence for two types
of abnormalities. Journal of Laboratory and Clin-
ical Medicine, 106, 326–335.
Noris, P., Pecci, A., Di Bari, F., Di Stazio, M.T.,
Di Pumpo, M., Ceresa, I.F., Arezzi, N., Ambaglio,
C., Savoia, A. & Balduini, C.L. (2004) Application
of a diagnostic algorithm for inherited thrombocy-
topenias to 46 consecutive patients. Haematologica,
89, 1219–1225.
Noris, P., Klersy, C., Zecca, M., Arcaini, L., Pecci,
A., Melazzini, F., Terulla, V., Bozzi, V., Amba-
glio, C., Passamonti, F., Locatelli, F. & Balduini,
C.L. (2009) Platelet size distinguishes between
inherited macrothrombocytopenias and immune
thrombocytopenia. Journal of Thrombosis and
Haemostasis, 7, 2131–2136.
Noris, P., Perrotta, S., Seri, M., Pecci, A., Gnan,
C., Loffredo, G., Pujol-Moix, N., Zecca, M.,
Scognamiglio, F., De Rocco, D., Punzo, F.,
Melazzini, F., Scianguetta, S., Casale, M., Marconi,
C., Pippucci, T., Amendola, G., Notarangelo, L.D.,
Klersy, C., Civaschi, E., Balduini, C.L. & Savoia, A.
(2011) Mutations in ANKRD26 are responsible for
a frequent form of inherited thrombocytopenia:
analysis of 78 patients from 21 families. Blood, 117,
6673–6680.
Noris, P., Perrotta, S., Bottega, R., Pecci, A.,
Melazzini, F., Civaschi, E., Russo, S., Magrin, S.,
Loffredo, G., Di Salvo, V., Russo, G., Casale, M.,
De Rocco, D., Grignani, C., Cattaneo, M.,
Baronci, C., Dragani, A., Albano, V., Jankovic,
M., Scianguetta, S., Savoia, A. & Balduini, C.L.
(2012) Clinical and laboratory features of 103
patients from 42 Italian families with inherited
thrombocytopenia derived from the monoallelic
Ala156Val mutation of GPIba (Bolzano muta-
tion). Haematologica, 97, 82–88.
Provan, D., Stasi, R., Newland, A.C., Blanchette,
V.S., Bolton-Maggs, P., Bussel, J.B., Chong,
B.H., Cines, D.B., Gernsheimer, T.B., Godeau,
B., Grainger, J., Greer, I., Hunt, B.J., Imbach,
P.A., Lyons, G., McMillan, R., Rodeghiero, F.,
Sanz, M.A., Tarantino, M., Watson, S., Young,
J. & Kuter, D.J. (2010) International consensus
report on the investigation and management of
primary immune thrombocytopenia. Blood, 115,
168–186.
Savoia, A., Pastore, A., De Rocco, D., Civaschi, E.,
Di Stazio, M., Bottega, R., Melazzini, F., Bozzi,
V., Pecci, A., Magrin, S., Balduini, C.L. & Noris,
P. (2011) Clinical and genetic aspects of
Bernard-Soulier syndrome: searching for geno-
type/phenotype correlations. Haematologica, 96,
417–423.
Platelet Size in Inherited Thrombocytopenias
ª 2013 John Wiley & Sons Ltd 119
British Journal of Haematology, 2013, 162, 112–119
